Peptide research moves quickly, but the language used to describe peptides often lags behind the nuance of what researchers actually need. A single label line (for example, a sequence with “Ac-” and “-NH2”) can carry assumptions about terminal chemistry, analytical confirmation, and even how the material’s mass is reported on documentation. In purchasing and reporting, imprecise terminology can also lead to mismatched expectations—particularly around purity, content, salt form, and identity testing.
This article explains peptide terminology in a practical, laboratory-research context. The goal is not to provide medical or treatment guidance, but to clarify the terms that appear in catalogues, method sections, laboratory notebooks, analytical reports, and Certificates of Analysis (CoAs). If you want introductory context before diving into terminology, see what peptides are and the broader comparison in peptides vs proteins.
Why peptide terminology matters in research supply and documentation
Peptides are described across multiple “languages” at once: synthetic chemistry, analytical chemistry, and molecular biology. Terms like sequence, residue, purity, salt form, and confirmed by MS may sound straightforward, yet they can refer to different measurement conventions or reporting choices.
In practice, terminology matters most in four situations:
- Ordering and receiving materials: ensuring the delivered material matches the intended sequence, modifications, and quality grade.
- Method reproducibility: accurately describing a peptide so that another lab can source and verify the same material.
- Analytical interpretation: understanding what an HPLC chromatogram or mass spectrum does (and does not) confirm.
- Data management: mapping identifiers (sequence strings, batch numbers, and modifications) consistently across inventory, ELNs, and publications.
The sections below focus on the peptide terminology that most commonly affects those workflows.
Peptides, polypeptides, and proteins: the chain-length vocabulary
Peptide vs polypeptide
Both peptides and polypeptides are chains of amino acid residues linked by peptide bonds. The difference is largely contextual rather than absolute: “polypeptide” often implies a longer chain than “peptide,” but the cutoff varies by field and even by supplier catalogues. Some disciplines reserve “polypeptide” for chains approaching protein-like lengths, while others use it simply as a synonym for “peptide chain.”
Because of this ambiguity, research documentation is usually clearer when it includes the exact sequence and the number of residues, rather than relying on a length-based label alone.
Peptides vs proteins
Proteins are typically longer polypeptide chains that adopt higher-order structure (secondary, tertiary, and sometimes quaternary). In peptide-focused studies, “protein” may also imply recombinant expression, folding considerations, and post-translational modifications that are not always present in synthetic peptides. A concise overview of these distinctions is available in peptides vs proteins.
Sequence notation: how peptides are written (and misread)
Amino acids, residues, and the meaning of “sequence”
In peptide terminology, the word residue refers to an amino acid unit within a chain after incorporation via peptide bond formation (i.e., after losing the elements of water relative to the free amino acid). This distinction matters in mass calculations and in interpreting formulae.
A peptide’s sequence can be written using:
- One-letter codes (e.g., “ACDE…”) common in bioinformatics and ordering forms.
- Three-letter codes (e.g., “Ala-Cys-Asp…”) often used in manuscripts and teaching materials.
Sequences are conventionally written from the N-terminus to the C-terminus. When a sequence is copied into an order form or ELN, confirming directionality helps prevent an easy but consequential error.
N-terminus and C-terminus
The N-terminus is the “amino end” of the peptide chain, and the C-terminus is the “carboxyl end.” Many peptide descriptors—especially terminal modifications—are shorthand instructions applied specifically to these ends. In practice:
- Most catalogues assume a free N-terminus and a free C-terminus unless modifications are specified.
- Some peptides are deliberately capped to remove terminal charges or to mimic naturally occurring processing.
Even when the internal sequence is unchanged, altering termini can change measured mass, chromatographic behaviour, and apparent solubility. For a structured overview of common modifications and their notation, see this peptide modifications guide.
What “Ac-” and “-NH2” mean
Two of the most common pieces of peptide terminology in ordering and labelling are:
- “Ac-”: typically indicates N-terminal acetylation (addition of an acetyl group at the N-terminus).
- “-NH2”: typically indicates C-terminal amidation (conversion of the C-terminal carboxyl group into an amide).
These are not cosmetic annotations. They affect the peptide’s monoisotopic and average mass, can change the net charge at a given pH, and may shift HPLC retention under specific conditions. Importantly for recordkeeping, the “same” peptide sequence with different terminal chemistry should be treated as a different entity in inventory systems and experimental metadata.
Disulfide bonds and cysteine terminology
Cysteine residues introduce a common source of terminology confusion. A label may specify:
- “Reduced”: cysteines are present as thiols (no disulfide linkage specified).
- “Oxidised” or “disulfide bonded”: indicates formation of one or more disulfide bridges.
Disulfide state changes the observed mass (relative to reduced forms) and often affects chromatographic profiles. It can also create multiple possible connectivities in peptides with more than two cysteines, which may require dedicated analytical confirmation beyond a single mass measurement.
Stereochemistry and “L-” vs “D-” amino acids
Unless stated otherwise, amino acids in synthetic peptides are typically assumed to be L-configured. When a sequence includes a D-amino acid, this must be explicitly specified in the ordering and naming conventions (e.g., using “dAla” in three-letter notation or a supplier-specific annotation in one-letter strings).
Stereochemistry matters because L- and D- forms share the same nominal mass but can differ in chromatographic retention and conformational behaviour. As a result, “confirmed by MS” alone cannot distinguish stereoisomers.
Modification terminology: beyond the bare sequence
In peptide terminology, modification can mean anything that changes the chemical composition relative to an unmodified chain with free termini. Common categories include terminal capping (acetylation/amidation), side-chain functionalisation (e.g., phosphorylation mimics), conjugation handles (e.g., biotin, fluorophores), and incorporation of non-canonical residues (e.g., norleucine or other analogues).
In purchasing and reporting, modification terminology is most reliable when it is expressed in three complementary ways:
- Explicit text notation (e.g., “N-terminal acetylated, C-terminal amidated”).
- A modified sequence string (e.g., “Ac-XXXX-NH2”).
- Expected mass (monoisotopic and/or average), allowing an analytical check.
A dedicated reference to common modification notation and implications is available at peptide modifications guide.
Purity, content, and quality: the terms that drive purchasing decisions
Few parts of peptide terminology cause more confusion than “purity.” Researchers often need to differentiate chromatographic purity (a method-dependent metric) from peptide content (a composition metric). These are related but not interchangeable.
HPLC purity (what it usually means)
HPLC purity is typically reported as the percentage area of the main peak relative to total detected peak area under a specific method (column chemistry, gradient, mobile phases, wavelength, and integration settings). It is best understood as HPLC-method purity, not an absolute statement of chemical composition.
Key implications:
- Different HPLC methods can yield different apparent purities for the same sample.
- Some impurities may not be detected well at the chosen wavelength.
- Co-eluting species can inflate apparent purity if they overlap with the main peak.
For a deeper discussion of definitions and typical reporting conventions, see peptide purity explained.
Peptide content (what it usually means)
Peptide content refers to how much of the supplied material’s mass is attributable to the peptide itself, as opposed to residual solvents, water, buffer components, and counterions (salt forms). A vial labelled “5 mg” is typically a mass of the total material supplied, which may include non-peptide components depending on preparation and storage history.
Content is often assessed using approaches such as amino acid analysis, quantitative NMR, or carefully controlled UV methods with appropriate extinction coefficients (method choice depends on peptide composition and available instrumentation). Content and purity can diverge in either direction; for example, a sample can show a clean chromatographic main peak but still contain substantial non-peptide mass (e.g., salts or water).
“Research grade,” “purified,” and “crude” peptide
Suppliers and labs may use quality grade terminology as shorthand for expected impurity profiles and the extent of downstream cleanup.
- Crude peptide: typically indicates material after synthesis and initial workup, but before extensive purification. It often contains truncated sequences, deletion products, and side products.
- Purified peptide: generally indicates additional purification steps (commonly preparative chromatography) were used to enrich the target component.
Because “purified” can still cover a range of outcomes, it is good practice to rely on accompanying analytics (HPLC trace, MS) rather than the grade label alone.
Salt forms and counterions: TFA, acetate, and what “salt” actually means
Many peptides are supplied as a salt form. This reflects the counterion associated with ionisable groups on the peptide following synthesis and purification workflows. Two commonly encountered counterions are:
- TFA (trifluoroacetate), often associated with TFA-based HPLC mobile phases.
- Acetate, sometimes used when peptides are converted to a different counterion (for compatibility with certain downstream applications or reporting preferences).
Terminology to recognise:
- “TFA salt” or “trifluoroacetate salt”: indicates trifluoroacetate is present as the primary counterion.
- “Acetate salt”: indicates acetate is present as the primary counterion.
- “Free base” or “free acid”: sometimes used to indicate minimal associated counterions (usage varies and should be clarified with supporting analytics).
Salt form matters because counterions contribute to the total mass of the material, can influence how molecular weight is reported, and may affect certain analytical readouts. A focused explanation is provided in peptide salt forms: TFA vs acetate.
Mass spectrometry terminology: what “confirmed by MS” typically implies
Mass spectrometry (MS) is widely used for peptide identity checks. In peptide terminology, phrases like “MS confirmed” or “confirmed by MS” generally mean the observed mass is consistent with the expected molecular mass for the target sequence and stated modifications.
It is important to interpret this precisely:
- MS confirmation supports identity but does not necessarily prove full sequence correctness, especially for isomers (e.g., Leu/Ile) or stereochemical variants (L vs D).
- Depending on the method, MS may not resolve closely related impurities that share similar mass.
- Adducts (e.g., sodium or potassium) can produce additional peaks; interpreting these requires familiarity with the method and sample history.
MALDI-TOF vs ESI: ionisation language that appears on CoAs
Two common MS approaches in peptide workflows are:
- MALDI-TOF (Matrix-Assisted Laser Desorption/Ionisation Time-of-Flight): often produces spectra with fewer charge states (frequently singly charged ions), which can simplify quick mass checks for many peptides.
- ESI (Electrospray Ionisation): commonly produces multiple charged states, which can be advantageous for larger peptides and for coupling to liquid chromatography (LC-MS).
Both approaches can be appropriate for identity support. When comparing results across documents, note that reported masses may refer to different peak annotations (monoisotopic vs average; protonated molecule vs adduct; charge-state deconvolution practices).
HPLC vs LC-MS: terminology around “purity by HPLC” and “LC-MS trace”
In peptide analytics, HPLC and LC-MS are frequently paired but they answer different questions. HPLC with UV detection is often used for a routine purity estimate under defined chromatographic conditions. LC-MS combines separation with mass detection, which can help connect chromatographic peaks to mass identities.
Because naming can vary across labs and suppliers, it helps to keep the terms explicit in documentation (e.g., “RP-HPLC UV at 214 nm” vs “LC-ESI-MS total ion chromatogram”). A dedicated comparison is available at HPLC vs LC-MS for peptides.
Chromatography terminology: how peptides are separated and reported
Even when a report simply says “HPLC purity,” several embedded terms affect how results should be read.
RP-HPLC and “retention time” (RT)
RP-HPLC refers to reverse-phase HPLC, a common method for peptide separation. The retention time (RT) is the time at which a peak elutes under a specified method. RT is useful for within-method comparison, but it is not a universal identifier: changing the column, gradient, temperature, or solvents can shift RT substantially.
Peak area, integration, and “main peak” language
Peak area % depends on how peaks are integrated, the detection wavelength, and baseline handling. When a CoA reports a single purity percentage, it is typically summarising a specific integration outcome. For transparency in internal lab records, many teams store the chromatogram image or raw data alongside the numeric purity value.
Physical form and handling terminology: lyophilised, hygroscopic, and related terms
Lyophilised (freeze-dried)
Lyophilised means freeze-dried. In research supply, lyophilisation is commonly used to provide peptides as dry solids to improve handling and storage convenience. “Dry” does not necessarily mean “water-free,” as many peptides are at least somewhat hygroscopic (able to absorb moisture from air), which can affect weighing consistency and apparent mass over time.
Hygroscopic and “sticky” peptides
Some peptides readily absorb moisture and may appear oily or sticky when exposed to ambient air. This is not inherently an indicator of poor quality; it may reflect the peptide’s composition, salt form, or residual solvent/water content. In lab documentation, it can be useful to note physical observations (powder vs film) and the handling conditions used.
Solubility terminology (and why it’s often underspecified)
“Solubility” is frequently used in a broad way, but in peptide research it depends strongly on pH, ionic strength, temperature, and the presence of organic co-solvents. Supplier notes may provide general guidance, but reproducible work typically requires recording the actual preparation conditions used in the experiment. For terminology commonly used in storage and handling documentation, see peptide storage and handling terms.
Certificates of Analysis (CoA): terminology that appears on peptide documentation
A Certificate of Analysis (CoA) is a batch-specific document that typically lists identifying information and analytical results. For labs operating under structured documentation practices, the CoA is also a key artifact for traceability.
Common CoA fields and what the terminology generally implies include:
- Peptide name / code: a human-readable identifier that may not uniquely define the chemistry unless paired with the sequence and modifications.
- Sequence: may be shown in one-letter code and may include terminal modification notation.
- Batch/Lot number: essential for traceability, particularly when repeating work months later.
- Molecular weight (MW): sometimes reported as monoisotopic or average; ambiguity should be clarified if the value is used for calculations or identity checks.
- Purity: often an HPLC area % under specified conditions (method details may be on the CoA or available on request).
- Identity: frequently stated as “confirmed by MS,” with an accompanying spectrum or mass value.
- Salt form: may be explicitly stated (e.g., TFA or acetate), or implied by method history.
If you want a walkthrough of how to interpret these fields consistently, see reading a Certificate of Analysis (CoA).
Common peptide terminology pitfalls (and how to avoid them in lab records)
Assuming “purity” equals “only peptide”
Chromatographic purity is not the same as peptide content. In internal documentation, it is clearer to record both the reported HPLC purity and any content measurement (if available), along with the salt form. This avoids confusion when comparing vials across batches or suppliers.
Using sequence strings without modification metadata
Two peptides can share the same residue sequence but differ meaningfully in terminal chemistry, stereochemistry, or conjugation. In ELNs and sample labels, storing a single “sequence” field can be insufficient unless it also captures modifications unambiguously.
Interpreting MS confirmation as full structural proof
MS is powerful for confirming mass consistency, but it may not discriminate isomers or stereochemical variants. If an application depends on those distinctions, researchers typically plan orthogonal verification (for example, targeted LC methods, MS/MS sequence ions, or additional structural analytics appropriate to the project).
Not recording the analytical method behind reported numbers
When results are compared across reports, method details matter. Recording the HPLC method (column type, gradient, detection wavelength) and MS approach (MALDI vs ESI; deconvolution practices) makes “purity” and “mass” values interpretable months later.
FAQ: peptide terminology questions researchers actually ask
What is the difference between a peptide and a polypeptide?
Both are chains of amino acid residues linked by peptide bonds. In practice, “polypeptide” often implies a longer chain than “peptide,” but the exact cutoff varies by field and context.
What do N-terminus and C-terminus mean?
They refer to the two ends of a peptide chain. By convention sequences are written from the N-terminus (amino end) to the C-terminus (carboxyl end).
What does “Ac-” and “-NH2” mean in a peptide sequence?
“Ac-” typically denotes N-terminal acetylation, and “-NH2” typically denotes C-terminal amidation—both are common terminal modifications that change the peptide’s reported mass and properties.
What is HPLC purity and how is it different from peptide content?
HPLC purity usually refers to the main peak area percentage under specified chromatographic conditions, while peptide content refers to how much of the material is actually the peptide (accounting for salts, water, and residuals).
Why does my peptide have a TFA salt or acetate salt?
The “salt form” indicates the counterion associated with the peptide after synthesis and purification. It’s common and can influence how mass and composition are reported on documentation.
What does “confirmed by MS” mean?
It generally means mass spectrometry was used to verify the peptide’s molecular mass is consistent with the expected sequence (and any modifications). It does not necessarily imply full sequence verification.
What’s the difference between MALDI-TOF and ESI mass spectrometry?
They are different ionisation approaches used in mass spectrometry. ESI commonly produces multiple charged states, while MALDI often produces fewer charge states; both can be used for peptide identity checks.
What does “crude peptide” mean?
It typically refers to material after synthesis and initial processing but before extensive purification. “Purified” indicates additional steps (often chromatography) were used to reduce by-products.
What does “lyophilised” mean on a peptide label?
Lyophilised means freeze-dried. In research supply, this commonly indicates the peptide is provided as a dry solid to improve handling and storage convenience.
What is a Certificate of Analysis (CoA) for peptides?
A CoA is a batch-specific document that typically lists the peptide name/sequence, batch number, analytical results (such as HPLC and MS), and reported purity/identity statements.
Clear peptide terminology is less about memorising definitions and more about specifying what you mean: the exact sequence direction, terminal chemistry, salt form, the analytical method behind “purity,” and what MS confirmation actually covered. When those details are captured consistently, purchasing, documentation, and downstream analytics become easier to interpret and reproduce.